Covid-19 vaccines

Novavax, Inc (NASDAQ: NVAX) shares fell over 12% in the after-hours trading on Monday after closing almost 8.8% lower in regular trading. What Happened: The after-hours dip came as the Maryland-based company said that it is unlikely to seek emergency use authorization for its COVID-19 vaccine...

The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. What Happened: The FDA said it has amended the emergency use authorization (EUA) originally...

Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: TSLA) and Nio Inc (NYSE: NIO) in the first quarter and bought shares in vaccine maker Moderna Inc (NASDAQ: MRNA), regulatory filings reveal. What Happened: Baillie Gifford, a 110-year-old...

Shares of biotechnology company Moderna Inc. (NASDAQ: MRNA) fell more than 6% in Wednesday’s regular trading session, but rebounded more than 1% in the extended session. What Happened: The after-hours surge came as Moderna reported the effectiveness of its COVID-19 vaccine against variants in...

The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know. Waterdrop: Working with insurance companies, Waterdrop (NYSE: WDH) seeks to...

Pfizer Inc. (NYSE: PFE) has started exporting COVID-19 vaccine doses produced in its U.S. plant to Mexico, Reuters reported Thursday, citing a person familiar with the matter. What Happened: The shipment of vaccine doses from Pfizer’s Kalamazoo, Michigan plant to Mexico is the first export...

Biopharmaceutical company Ocugen Inc.’s (NASDAQ: OCGN) COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival AstraZeneca plc (NASDAQ: AZN) for its vaccines in India. What Happened: Bharat Biotech announced on Twitter it will sell...

Johnson & Johnson’s (NYSE: JNJ) single-shot COVID-19 vaccine is expected to be imported to India for the fill and finish process over the next two to three months, according to a report by the Indian financial daily Mint. What Happened: JNJ is in talks with Indian pharmaceutical company...

Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a...

White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on administering the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine and get the vaccine “back on track.” What Happened: Fauci made the comments in an interview...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has come in support of COVID-19 vaccines after his earlier stance on social media sparked a debate surrounding the safety of a second shot. What Happened: Musk made it clear that he supported vaccines and COVID-19 vaccines specifically.  To be clear...

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have started clinical trials of their jointly-developed COVID-19 vaccine with children, the companies said in a statement Thursday. What Happened: The vaccine trials involve healthy participants aged 6 months to 11-years and the first...

AstraZeneca Plc (NASDAQ: AZN) on Wednesday issued a fresh update of its phase three trial data for the COVID-19 vaccine after a U.S. health agency earlier this week questioned the accuracy of the trial data. What Happened: The British drugmaker’s latest update claims the vaccine developed...

Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine is expected to get a significant supply boost after manufacturing partner Catalent Inc (NYSE: CTLT) secured a key U.S. regulator clearance, Bloomberg News reported on Tuesday. What Happened: A U.S. Food and Drug Administration’s...

AstraZeneca Plc (NYSE: AZN) may have included outdated data related to the U.S. trials of its COVID-19 vaccine that resulted in an incomplete view of the efficacy data, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Monday. What Happened: The British drugmaker had...